Home Health Residents urged to take up invitation to help trial new NHS cancer screening test
Man having blood taken by a nurser as part of NHS-Galleri trial.

Residents urged to take up invitation to help trial new NHS cancer screening test

by Laura Johnston

People from Knowsley are being reminded to return to help the NHS research a pioneering test to detect cancer earlier.

Participants in Knowsley are now receiving an invitation to have a final blood sample taken at a mobile clinic stationed at Asda in Huyton, from February 12th to February 22nd.

It will be the last of three blood samples taken for the NHS-Galleri trial, which 22,000 people in Merseyside and Cheshire are taking part in. The study is investigating if the multi-cancer blood screening test can help to spot cancer before symptoms appear.

Dr Chris Warburton, Medical Director at Cheshire and Merseyside Cancer Alliance, said:

“We are delighted to be welcoming back volunteers from Knowsley for their last trial appointment and we are truly grateful for their ongoing participation. Even if you missed your appointment last year, your involvement this year will still help with this research.


“This trial – launched nationally in Cheshire and Merseyside in 2021 – continues to put the NHS at the forefront of ground-breaking research and technology. If this trial is a success, the Galleri blood test could play a major part in achieving the NHS Long Term Plan ambition to diagnose three quarters of cancers at an early stage when they are easier to treat.”

Early research has shown that the Galleri test could help to detect cancers that are typically difficult to identify early – such as head and neck, bowel, lung, pancreatic, and throat cancers.

NHS-Galleri trial

The NHS-Galleri trial is being run by The Cancer Research UK and King’s College London Cancer Prevention Trials Unit in partnership with the NHS and healthcare company, GRAIL, which has developed the Galleri test. The trial is operating with the support of eight NHS cancer alliances across England, including Cheshire and Merseyside, and it is rolling out across our region until June 2024.

The test works by analysing chemical patterns in fragments of DNA that are shed from tumours into the bloodstream. If early trial results are promising, the NHS may decide to pilot the delivery of the test to a further one million people.

For more information on the trial, see https://www.nhs-galleri.org